Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BLAST: Postoperative Analgesia in Hip and Knee Replacement Surgery
NCT06230081Active, not recruiting
- Sponsor
- Region Skåne
- Start
- Feb 2024
- Primary completion
- Mar 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of ropivacaine and clonidine in postoperative pain (2 arms), sponsored by Region Skåne. Primary endpoint: Difference in Postoperative pain assessed by NRS at 14 days. Started Feb 2024; status: active, not recruiting.
02
Drugs
ropivacaineclonidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06230081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06230081.